Gendered Innovations in the Study of Cardiovascular Diseases

  • Evgeny ShlyakhtoEmail author
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1065)


The chapter summarizes modern knowledge on gender aspects of major cardiovascular diseases starting from basic research. It covers arterial hypertension along with treatment aspects in males and females, as well as menopausal replacement therapy and testosterone use. Authors analyze both literature and original data on obesity and metabolic syndrome, coronary artery disease, arrhythmias including gender aspects of sudden cardiac death, cardiomyopathies, and diseases of aorta and aortic valve. A significant part deals with cardiac imaging and sex differences.


Gendered innovations Translational research Basic science Cardiovascular system Sex-specific difference Metabolic syndrome Heart failure Diabetic cardiomyopathy Cardiac amyloidosis Adiponectin Bariatric procedure Cardioprotection Review 


  1. 1.
    Al-Alao BS, Parissis H, McGovern E, Tolan M, Young VK. Gender influence in isolated coronary artery bypass graft surgery: a propensity match score analysis of early outcomes. Gen Thorac Cardiovasc Surg. 2012;60:417–24.PubMedCrossRefPubMedCentralGoogle Scholar
  2. 2.
    Angelini P. Coronary artery anomalies—current clinical issues: definitions, classification, incidence, clinical relevance, and treatment guidelines. Tex Heart Inst J. 2002;29:271–8.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Arbelo E, Brugada P, Blomstrom-Lundquist C, et al. Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry. Europace. 2017;38(17):1303–16.Google Scholar
  4. 4.
    Aydar Y, Yazici HU, Birdane A, Nasifov M, Nadir A, Ulus T, et al. Gender differences in the types and frequency of coronary artery anomalies. Tohoku J Exp Med. 2011;225:239–47.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Bae S, Zhang L. Gender differences in cardioprotection against ischemia/reperfusion injury in adult rat hearts: focus on Akt and protein kinase C signaling. J Pharmacol Exp Ther. 2005;315:1125–35.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Bayorh MA, et al. The role of gender in salt-induced hypertension. Clin Exp Hypertens. 2001;23:241–55.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Behere SP, Weindling SN. Catecholaminergic polymorphic ventricular tachycardia: an exciting new era. Ann Pediatr Cardiol. 2016;9(2):137–146. PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Berezina A, Belyaeva O, Berkovich O, Baranova E, Bazhenova E, Brovin D, Grineva E, Shlyakhto E. Prevalence, risk factors, and genetic traits in metabolically healthy and unhealthy obese individuals. BioMed Res Int. 2015;2015:548734. Scholar
  9. 9.
    Bigalke B, Phinikaridou A, Andia ME, et al. Positron emission tomography/computed tomographic and magnetic resonance imaging in a murine model of progressive atherosclerosis using 64Cu-labeled glycoprotein VI-Fc. Circ Cardiovasc Imaging. 2013;6:957–64.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Blake HA, Manion WC, Mattingly TW, Baroldi G. Coronary artery anomalies. Circulation. 1964;30:927–40.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Blankstein R, Ward RP, Arnsdorf A, Jones B, Lou YB, Pine M. Female gender is an independent predictor of operative mortality after coronary artery bypass graft surgery: contemporary analysis of 31 Midwestern hospitals. Circulation. 2005;112:I323–7.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Bode K, Breithardt OA, Kreuzhuber M, Mende M, Sommer P, Richter S, et al. Patient discomfort following catheter ablation and rhythm device surgery. Europace. 2015;17:1129–35.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Booth EA, et al. Activation of estrogen receptor-alpha protects the in vivo rabbit heart from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2005;289:H2039–H204.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Boriani G, Lorenzetti S, Cerbai E, Oreto G, et al. The effects of gender on electrical therapies for the heart: physiology, epidemiology, and access to therapies: a report from the XII Congress of the Italian Association on Arrhythmology and Cardiostimulation (AIAC). Europace. 2017;19:1418–26. Scholar
  15. 15.
    Bouma W, et al. Sex-related resistance to myocardial ischemia-reperfusion injury is associated with high constitutive ARC expression. Am J Physiol Heart Circ Physiol. 2010;298:H1510–7.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran C, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987;75(6):1102–9.CrossRefPubMedGoogle Scholar
  17. 17.
    Butter C, Schau T, Meyhoefer J, Neumann K, Minden HH, Engelhardt J. Radiation exposure of patient and physician during implantation and upgrade of cardiac resynchronization devices. Pacing Clin Electrophysiol. 2010;33:1003–12.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Carnlof C, Insulander P, Jensen-Urstad M. An active supply of analgesics during pulmonary vein isolation reduces pain. Scand Cardiovasc J. 2014;48:35–40.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Cha Y-M, Lloyd MA, Birgersdotter-Green UM. Arrhythmias in women: diagnosis and management. Oxford: Oxford University Press; 2014.CrossRefGoogle Scholar
  20. 20.
    Chakrabarti S, Lekontseva O, Davidge ST. Estrogen is a modulator of vascular inflammation. IUBMB Life. 2008;60(6):376–82.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Cheetham TC, An J, Jacobsen SJ, Niu F, Sidney S, Quesenberry CP, et al. Association of testosterone replacement with cardiovascular outcomes among men with androgen deficiency. JAMA Int Med. 2017;177:491–9.CrossRefGoogle Scholar
  22. 22.
    Chen Q, et al. An association between gene expression and better survival in female mice following myocardial infarction. J Mol Cell Cardiol. 2010;49:801–11.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Consideration of Sex as a Biological Variable in NIH-funded Research. 2015.
  24. 24.
    Corona G, Sforza A, Maggi M. Testosterone replacement therapy: long-term safety and efficacy. World J Mens Health. 2017;35:e2.CrossRefGoogle Scholar
  25. 25.
    Cygankiewicz I, Wranicz JK, et al. Clinical covariates of abnormal heart rate turbulence in coronary patients. Ann Noninvasive Electrocardiol. 2003;8(4):289–95.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Davis JP, Salmon M, Pope NH, Lu G, Su G, Sharma AK, Ailawadi G, Upchurch GR Jr. Attenuation of aortic aneurysms with stem cells from different genders. J Surg Res. 2015;199(1):249–58.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    De Saint-Hubert M, Bauwens M, Deckers N, et al. In vivo molecular imaging of apoptosis and necrosis in atherosclerotic plaques using microSPECT-CT and microPET-CT imaging. Mol Imaging Biol. 2014;16:246–54.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Diemberger I, Marazzi R, Casella M, et al. The effects of gender on electrical therapies for the heart: procedural considerations, results and complications. Europace. 2017;19:1911–21. Scholar
  29. 29.
    Dietrich T, Berndorff D, Heinrich T, et al. Targeted ED-B fibronectin SPECT in vivo imaging in experimental atherosclerosis. Q J Nucl Med Mol Imaging. 2015;59:228–37.PubMedPubMedCentralGoogle Scholar
  30. 30.
    Dilsizian V, Taillefer R. Journey in evolution of nuclear cardiology: will there be another quantum leap with the F-18-labeled myocardial perfusion tracers? JACC Cardiovasc Imaging. 2012;5:1269–84.PubMedCrossRefPubMedCentralGoogle Scholar
  31. 31.
    Dimitrow PP, Czarnecka D, Kawecka-Jaszcz K, Dubiel JS. The influence of age on gender-specific differences in the left ventricular cavity size and contractility in patients with hypertrophic cardiomyopathy. Int J Cardiol. 2003;88(1):11–6.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Dogan M, Yiginer O, Uz O, Kucuk U, et al. The effects of female sex hormones on ventricular premature beats and repolarization parameters in physiological menstrual cycle. Pacing Clin Electrophysiol. 2016;39:418–26.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Douglas PS, et al. Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. J Am Coll Cardiol. 1998;32:1118–25.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Edson E, Whyte M, van Vlymen J, et al. Bariatric surgery in obese women of reproductive age improves conditions that underlie fertility and pregnancy outcomes: retrospective cohort study of National Bariatric Surgery Registry (NBSR). Obes Surg. 2016;26:2837–42.CrossRefGoogle Scholar
  35. 35.
    Einstein AJ, Henzlova MJ, Rajagopalan S. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA. 2007;298:317–23.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Enriquez AD, Economy KE, Tedrow UB. Contemporary management of arrhythmias during pregnancy. Circ Arrhythmia Electrophysiol. 2014;7:961–7.CrossRefGoogle Scholar
  37. 37.
    Ezzat VA, Chew A, McCready JW, Lambiase PD, Chow AW, Lowe MD, et al. Catheter ablation of atrial fibrillation-patient satisfaction from a single-center UK experience. J Interv Cardiac Electrophysiol. 2013;37:291–303.CrossRefGoogle Scholar
  38. 38.
    Fairweather D, Cooper LT, Blauwet LA. Sex and gender differences in myocarditis and dilated cardiomyopathy. Curr Probl Cardiol. 2013;38(1):7–46. Scholar
  39. 39.
    Fang L, et al. Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction. J Mol Cell Cardiol. 2007;43:535–44.PubMedCrossRefGoogle Scholar
  40. 40.
    Fernandez-Sola J, Estruch R, Nicolas JM, Pare JC, Sacanella E, Antunez E, Urbano-Marquez A. Comparison of alcoholic cardiomyopathy in women versus men. Am J Cardiol. 1997;80:481–5.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Finan B, Yang B, Ottaway N, Stemmer K, Muller TD, Yi CX, et al. Targeted estrogen delivery reverses the metabolic syndrome. Nat Med. 2012;18:1847–56.PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Finkle WD, Greenland S, Ridgeway GK, Adams JL, Frasco MA, Cook MB, et al. Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS One. 2014;9:e85805.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Gardner JD, et al. Gender differences in cardiac remodeling secondary to chronic volume overload. J Card Fail. 2002;8:101–7.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Gargiulo S, Gramanzini M, Mancini M. Molecular imaging of vulnerable atherosclerotic plaques in animal models. Int J Mol Sci. 2016;17:1511. Scholar
  45. 45.
    Gebbie AE. Premature ovarian failure. Menopause Int. 2008;14:96.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Giordano S, Hage FG, Xing D, Chen Y-F, Allon S, Chen C-J, Oparil S. Estrogen and cardiovascular disease: is timing everything? Am J Med Sci. 2015;350:27–35.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation. 2014;129:e28–e292.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Grady D et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin replacement study follow-up (HERS II). JAMA 2002;288(1):49–57.Google Scholar
  49. 49.
    Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Int Med. 2000;133:933–41.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Halbach M, Hickethier T, Madershahian N, et al. Acute on/off effects and chronic blood pressure reduction after long-term baroreflex activation therapy in resistant hypertension. J Hypertens. 2015;33:1697–703.PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Harvey R, Coffman KE, Miller VM. Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease. Women’s Health (Lond Engl). 2015;11:239–57.CrossRefGoogle Scholar
  52. 52.
    Hevener AL, Clegg DJ, Mauvais-Jarvis F. Impaired estrogen receptor action in the pathogenesis of the metabolic syndrome. Mol Cell Endocrinol. 2015;418:306–21.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Hodis HN, Mack WJ, Azen SP, et al. For the Women’s estrogen-progestin lipid lowering hormone atherosclerosis regression trial research group. N Engl J Med. 2003;349:535–45.PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Hodis HN, Mack WJ, Henderson VW, Shoupe D, Budoff MJ, Hwang-Levine J, Li Y, Feng M, Dustin L, Kono N, Stanczyk FZ, Selzer RH, Azen SP, ELITE Research Group. Vascular effects of early versus late postmenopausal treatment with estradiol. N Engl J Med. 2016;374:1221–31.PubMedPubMedCentralCrossRefGoogle Scholar
  55. 55.
    Hreiche R, Morissette P, Turgeon J. Drug-induced long QT syndrome in women: review of current evidence and remaining gaps. Gend Med. 2008;5(2):124–35. doi:10.1016/j.genm.2008.05.005.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Hsia J, Criqui MH, Rodabough RJ, et al. Estrogen plus progestin and the risk of peripheral arterial disease: the Women’s Health Initiative. Circulation. 2004;109:620e6.CrossRefGoogle Scholar
  57. 57.
    Hulley S. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. (1998);280(7):605.PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Iribarren C, Darbinian JA, Go AS, et al. Traditional and novel risk factors for clinically diagnosed abdominal aortic aneurysm: the Kaiser multiphasic health checkup cohort study. Ann Epidemiol. 2007;17:669e78.CrossRefGoogle Scholar
  59. 59.
    Jain M, et al. Influence of gender on the response to hemodynamic overload after myocardial infarction. Am J Physiol Heart Circ Physiol. 2002;283:H2544–50.PubMedCrossRefPubMedCentralGoogle Scholar
  60. 60.
    James AF, Choisy SC, Hancox JC. Recent advances in understanding sex differences in cardiac repolarization. Prog Biophys Mol Biol. 2007;94(3):265–319. Epub 2005 Jun 13PubMedCrossRefPubMedCentralGoogle Scholar
  61. 61.
    Johnson MS, et al. Sex differences in myocardial infarct size are abolished by sarcolemmal KATP channel blockade in rat. Am J Physiol Heart Circ Physiol. 2006;290:H2644–7.PubMedCrossRefPubMedCentralGoogle Scholar
  62. 62.
    Kallianos A, Panoutsopoulos A, Mermigkis C, et al. Sex differences of continuous positive airway pressure treatment on flow-mediated dilation in patients with obstructive sleep apnea syndrome. Clin Interv Aging. 2015;10:1361–7.PubMedPubMedCentralGoogle Scholar
  63. 63.
    Kannel WB, Wilson PW, D’Agostino RB, Cobb J. Sudden coronary death in women. Am Heart J. 1998;136(2):205–12.PubMedCrossRefPubMedCentralGoogle Scholar
  64. 64.
    Kay J, Dorbala S, Goyal A, et al. Influence of sex on risk stratification with stress myocardial perfusion Rb-82 positron emission tomography: results from the PET Prognosis Multicenter Registry. J Am Coll Cardiol. 2013;62:1866–76.PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Kelly TN, He J. Genomic epidemiology of blood pressure salt sensitivity. J Hypertens. 2012;30:861–73.PubMedCrossRefPubMedCentralGoogle Scholar
  66. 66.
    Kim JW, Seo S, Kim HS, et al. Comparative evaluation of the algorithms for parametric mapping of the novel myocardial PET imaging agent [18]F-FPTP. Ann Nucl Med. 2017;31:469–79. Scholar
  67. 67.
    Kim LK, Looser P, Swaminathan RV, Horowitz J, et al. Sex-based disparities in incidence, treatment, and outcomes of cardiac arrest in the United States, 2003–2012. J Am Heart Assoc. 2016;5(6):e003704. Scholar
  68. 68.
    Kong WK, Regeer MV, Ng AC. Differences in phenotypes of bicuspid aortic valve and Aortopathy: insights from a large multicenter, international registry. Circ Cardiovasc Imaging. 2017;10(3):e005155.PubMedCrossRefPubMedCentralGoogle Scholar
  69. 69.
    Kritikou I, Basta M, Vgontzas AN, et al. Sleep apnoea and the hypothalamic-pituitary-adrenal axis in men and women: effects of continuous positive airway pressure. Eur Respir J. 2016;47:531–40.PubMedCrossRefPubMedCentralGoogle Scholar
  70. 70.
    Laitinen I, Saraste A, Weidl E, et al. Evaluation of αvβ3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice. Circ Cardiovasc Imaging. 2009;2:331–8.PubMedCrossRefPubMedCentralGoogle Scholar
  71. 71.
    Lampert R, McPherson A, Clancy JF, et al. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators. J Am Coll Cardiol. 2004;43:2293–9.PubMedCrossRefPubMedCentralGoogle Scholar
  72. 72.
    Lederle FA, Larson JC, Margolis KL, et al. Abdominal aortic aneurysm events in the women’s health initiative: cohort study. BMJ. 2008;337:a1724.PubMedPubMedCentralCrossRefGoogle Scholar
  73. 73.
    Lee SH, Tai CT, Hsieh MH, et al. Predictors of non-pulmonary vein ectopic beats initiating paroxysmal atrial fibrillation: implication for catheter ablation. J Am Coll Cardiol. 2005;46(6):1054–9.PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    Lew J, Sanghavi M, Ayers CR, et al. Sex-based differences in cardiometabolic biomarkers. Cicrulation. 2017;135:544–55.CrossRefGoogle Scholar
  75. 75.
    Li J, et al. The number of X chromosomes influences protection from cardiac ischaemia/reperfusion injury in mice: one X is better than two. Cardiovasc Res. 2014a;102:375–84.PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Li X, Bauer W, Israel I, et al. Targeting P-selectin by gallium-68-labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: correlation with in vivo 17.6T MRI. Arterioscler Thromb Vasc Biol. 2014b;34:1661–7.PubMedCrossRefPubMedCentralGoogle Scholar
  77. 77.
    Li Z, Wang Z, Yin Z, Zhang Y, Xue X, Han J, et al. Gender differences in fibrosis remodeling in patients with long-standing persistent atrial fibrillation. Oncotarget. 2017;8:53714–29. Scholar
  78. 78.
    Liang NL, Genovese EA, Al-Khoury GE, Hager ES, Makaroun MS, Singh MJ. Effects of gender differences on short-term outcomes in patients with type B aortic dissection. Ann Vasc Surg. 2017;38:78–83. Scholar
  79. 79.
    Lindenfeld J, Cleveland JC Jr, Kao DP, et al. Sex-related differences in age-associated downregulation of human ventricular myocardial β1-adrenergic receptors. J Heart Lung Transplant. 2016;35(3):352–61. CrossRefPubMedPubMedCentralGoogle Scholar
  80. 80.
    Mahmoodzadeh S, et al. 17beta-estradiol inhibits matrix metalloproteinase-2 transcription via MAP kinase in fibroblasts. Cardiovasc Res. 2010;85:719–28.PubMedCrossRefPubMedCentralGoogle Scholar
  81. 81.
    Mahmoodzadeh S, et al. Cardiomyocyte-specific estrogen receptor alpha increases angiogenesis, lymphangiogenesis and reduces fibrosis in the female mouse heart post-myocardial infarction. J Cell Sci Ther. 2014;5:153.PubMedPubMedCentralCrossRefGoogle Scholar
  82. 82.
    Makaryus AN, Sison C, Kohansieh M, et al. Implications of gender difference in coronary calcification as assessed by CT coronary angiography. Clin Med Insights Cardiol. 2014;8(Suppl 4):51–5.PubMedPubMedCentralGoogle Scholar
  83. 83.
    Makrygiannis G, Courtois A, Drion P, Defraigne JO, Kuivaniemi H, Sakalihasan N. Sex differences in abdominal aortic aneurysm: the role of sex hormones. Vasc Surg. 2014;28(8):1946–58. Scholar
  84. 84.
    Manfredini R, Fabbian F, Pala M, Tiseo R, De Giorgi A, Manfredini S, et al. Seasonal and weekly patterns of occurrence of acute cardiovascular diseases: does a gender difference exist? J Womens Health (Larchmt). 2011;20:1663–8.CrossRefGoogle Scholar
  85. 85.
    Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee J. Long-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2017;1:CD004143.PubMedPubMedCentralGoogle Scholar
  86. 86.
    Marroquin OC, Holubkov R, Edmundowicz D, et al. Heterogeneity of microvascular dysfunction in women with chest pain not attributable to coronary artery disease: implications for clinical practice. Am Heart J. 2003;145:628–35.PubMedCrossRefPubMedCentralGoogle Scholar
  87. 87.
    Masjedi S, Lei Y, Patel J, Ferdous Z. Sex-related differences in matrix remodeling and early osteogenic markers in aortic valvular interstitial cells. Heart Vessel. 2017;32(2):217–28.CrossRefGoogle Scholar
  88. 88.
    McCoy CM, Nicholas DQ, Masters KS. Sex-related differences in gene expression by porcine aortic valvular interstitial cells. PLoS One. 2012;7(7):e39980.PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340(23):1801–11.CrossRefPubMedGoogle Scholar
  90. 90.
    Meyer S, van der Meer P, van Tintelen JP, van den Berg MP. Sex differences in cardiomyopathies. Eur J Heart Fail. 2014;16:238–47. Scholar
  91. 91.
    Mikhaylov EN, Lebedev DS, Pokushalov EA, Davtyan KV, Ivanitskii EA, Nechepurenko AA, et al. Outcomes of cryoballoon ablation in high- and low-volume atrial fibrillation ablation centres: a Russian pilot survey. Biomed Res Int. 2015;2015, Article ID 591603, 8 pages. doi: Scholar
  92. 92.
    Min K-J, Lee C-K, Park H-N. The lifespan of Korean eunuchs. Curr Biol. 2012;22(18):R792–3.PubMedCrossRefPubMedCentralGoogle Scholar
  93. 93.
    Mori T, Kai H, Kajimoto H, et al. Enhanced cardiac inflammation and fibrosis in ovariectomized hypertensive rats: a possible mechanism of diastolic dysfunction in postmenopausal women. Hypertens Res. 2011;34:496–502.PubMedCrossRefPubMedCentralGoogle Scholar
  94. 94.
    Mosca L, Appel LJ, Benjamin EJ. Evidence-based guidelines for cardiovascular disease prevention in women. ACC Curr J Rev. 2004;13(5):29–30.CrossRefGoogle Scholar
  95. 95.
    Mozaffarian D, Benjamin EJ, Go AS, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–2015 update: a report from the American Heart Association. Circulation. 2015;131:e29–322.CrossRefPubMedPubMedCentralGoogle Scholar
  96. 96.
    Murphy E, Amanakis G, Fillmore N, et al. Sex differences in metabolic cardiomyopathy. Cardiovasc Res. 2017;113:370–7.PubMedCentralCrossRefGoogle Scholar
  97. 97.
    Nakagawa M, Takahashi N, Nobe S, Ichinose M, et al. Gender differences in various types of idiopathic ventricular tachycardia. J Cardiovasc Electrophysiol. 2002;13:633–8.PubMedCrossRefPubMedCentralGoogle Scholar
  98. 98.
    Nakamura T, Ogita M, Ako J, Momomura S. Gender differences of plaque characteristics in elderly patients with stable angina pectoris: an intravascular ultrasonic radiofrequency data analysis. Int J Vasc Med. 2010;134:692.Google Scholar
  99. 99.
    Nekolla SG, Reder S, Saraste A, et al. Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model. Circulation. 2009;119:2333–42.PubMedCrossRefPubMedCentralGoogle Scholar
  100. 100.
    Nikolic I, et al. Treatment with an estrogen receptor-beta-selective agonist is cardioprotective. J Mol Cell Cardiol. 2007;42:769–80.PubMedCrossRefPubMedCentralGoogle Scholar
  101. 101.
    Nordmeyer J, Eder S, Mahmoodzadeh Sh, Martus P, Fielitz J, Bass JN, Zurbrügg HR, , Roland Hetzer RP, Regitz-Zagrosek V. Upregulation of myocardial estrogen receptors in human aortic stenosis. Circulation 2004; 110: 3270–3275.PubMedCrossRefPubMedCentralGoogle Scholar
  102. 102.
    Nørgaard KS, Isaksen C, Buhl JS, et al. Single-centre cohort study of gender influence in coronary CT angiography in patients with a low to intermediate pretest probability of coronary heart disease. Open Heart. 2015;2:e000233. Scholar
  103. 103.
    Nuyt AM, Alexander BT. Developmental programming and hypertension. Curr Opin Nephrol Hypertens. 2009;18:144–52.PubMedPubMedCentralCrossRefGoogle Scholar
  104. 104.
    Olsson C, Thelin S, Stahle E, Ekbom A, Granath F. Thoracic aortic aneurysm and dissection: increasing prevalence and improved outcomes reported in a nationwide population-based study of more than 14,000 cases from 1987 to 2002. Circulation. 2006;114:2611–8.PubMedCrossRefPubMedCentralGoogle Scholar
  105. 105.
    Oparil S, Miller AP. Gender and blood pressure. J Clin Hypertens. 2005;7:300–9.CrossRefGoogle Scholar
  106. 106.
    Ostman-Smith I, Wettrell G, Keeton B, Holmgren D, Ergander U, Gould S, Bowker C, Verdicchio M. Age- and gender-specific mortality rates in childhood hypertrophic cardiomyopathy. Eur Heart J. 2008;29:1160–7. Scholar
  107. 107.
    Ou YC, Chuang HH, Li WC, et al. Gender difference in the association between lower muscle mass and metabolic syndrome independent of insulin resistance in middle-aged and elderly Taiwanese population. Arch Gerontol Geriatr. 2017;72:12–8.PubMedCrossRefPubMedCentralGoogle Scholar
  108. 108.
    Ouyang P, Michos ED, Karas RH. Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions. J Am Coll Cardiol. 2006;47:1741–53.PubMedCrossRefPubMedCentralGoogle Scholar
  109. 109.
    Padmanabhan S, Newton-Cheh C, Dominiczak AF. Genetic basis of blood pressure and hypertension. Trends Genet. 2012;28:397–408.PubMedCrossRefPubMedCentralGoogle Scholar
  110. 110.
    Padmanabhan S, Menni C, Lee WK, et al. The effects of sex and method of blood pressure measurement on genetic associations with blood pressure in the PAMELA study. J Hypertens. 2010;28:465–77.PubMedCrossRefPubMedCentralGoogle Scholar
  111. 111.
    Patel D, Mohanty P, Di Biase L, Sanchez JE, Shaheen MH, Burkhardt JD, et al. Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm. 2010;7:167–72.PubMedCrossRefPubMedCentralGoogle Scholar
  112. 112.
    Patten RD, et al. 17 Beta-estradiol differentially affects left ventricular and cardiomyocyte hypertrophy following myocardial infarction and pressure overload. J Card Fail. 2008;14:245–53.PubMedPubMedCentralCrossRefGoogle Scholar
  113. 113.
    Pedersen SB, Nielsen JC, Botker HE, Farkas DK, Schmidt M, Sorensen HT. Implantable cardioverter-defibrillators and subsequent cancer risk: a nationwide population-based cohort study. Europace. 2015;17:902–8.PubMedCrossRefPubMedCentralGoogle Scholar
  114. 114.
    Pereira TMC, Nogueira BV, Lima LCF, et al. Cardiac and vascular changes in elderly atherosclerotic mice: the influence of gender. Lipids Health Dis. 2010;9:87–96.PubMedPubMedCentralCrossRefGoogle Scholar
  115. 115.
    Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Böhm M, Duboc D, Gimeno J, de Groote P, Imazio M, Heymans S, Klingel K, Komajda M, Limongelli G, Linhart A, Mogensen J, Moon J, Pieper PG, Seferovic PM, Schueler S, Zamorano JL, Caforio AL, Charron P. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2016;37(23):1850–8. Scholar
  116. 116.
    Qi H, Liu Z, Liu B, Cao H, Sun W, Yan Y, Zhang L. Micro-RNA screening and prediction model construction for diagnosis of salt-sensitive essential hypertension. Medicine (Baltimore). 2017;96:e6417.CrossRefGoogle Scholar
  117. 117.
    Qin J, Peng C, Zhao B, Ye K, Yuan F, Peng Z, Yang X, Huang L, Jiang M, Zhao Q, et al. Noninvasive detection of macrophages in atherosclerotic lesions by computed tomography enhanced with PEGylated gold nanoparticles. Int J Nanomedicine. 2014;9:5575–90.PubMedPubMedCentralGoogle Scholar
  118. 118.
    Queiros AM, et al. Sex- and estrogen-dependent regulation of a miRNA network in the healthy and hypertrophied heart. Int J Cardiol. 2013;169:331–8.PubMedCrossRefPubMedCentralGoogle Scholar
  119. 119.
    Reckelhoff JF, et al. Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats. Hypertension. 1998;31:435–9.PubMedPubMedCentralCrossRefGoogle Scholar
  120. 120.
    Regitz-Zagrosek V, Kararigas G. Mechanistic pathways of sex differences in cardiovascular disease. Physiol Rev. 2017;97:1–37.PubMedPubMedCentralCrossRefGoogle Scholar
  121. 121.
    Reue K. Sex differences in obesity: X chromosome dosage as a risk factor for increased food intake, adiposity and co-morbidities. Physiol Behav. 2017;176:174–82.PubMedPubMedCentralCrossRefGoogle Scholar
  122. 122.
    Robinson DP, et al. Sex chromosome complement contributes to sex differences in coxsackievirus B3 but not influenza A virus pathogenesis. Biol Sex Differ. 2011;2:8.PubMedPubMedCentralCrossRefGoogle Scholar
  123. 123.
    Rodriguez I, Kilborn MJ, Liu XK, Pezzullo JC, et al. Drug-induced qt prolongation in women during the menstrual cycle. JAMA. 2001;285:1322–6. Scholar
  124. 124.
    Rosano GMC, Vitale C, Silvestri A, Fini M. Metabolic and vascular effects of progestins in post-menopausal women. Implications for cardioprotection. Maturitas. 2003;46:S17–29.PubMedCrossRefPubMedCentralGoogle Scholar
  125. 125.
    Sainz J, et al. Role of sex, gonadectomy and sex hormones in the development of nitric oxide inhibition-induced hypertension. Exp Physiol. 2004;89:155–62.PubMedCrossRefPubMedCentralGoogle Scholar
  126. 126.
    Schröder K, Wegscheider K, Wenger NK, Vettorazzi E, Schröder R. Resting electrocardiogram predicts mortality in postmenopausal women with coronary heart disease or with risk factors for coronary heart disease. Eur J Prev Cardiol. 2014;21(6):749–57. Epub 2012 Jun 29CrossRefPubMedPubMedCentralGoogle Scholar
  127. 127.
    Schuster I, et al. Cardiomyocyte-specific overexpression of oestrogen receptor beta improves survival and cardiac function after myocardial infarction in female and male mice. Clin Sci. 2016;130:365–76.PubMedCrossRefPubMedCentralGoogle Scholar
  128. 128.
    Scurrah K, Lamantia A, Ellis JA, Harrap SB. Familial analysis of epistatic and sex-dependent association of genes of the renin-angiotensin-aldosterone system and blood pressure. Circ Cardiovasc Genet. 2017;10(3):e001595.PubMedCrossRefPubMedCentralGoogle Scholar
  129. 129.
    Średniawa B, Mitręga KA, Cebula S, et al. Gender-dependent profile of heart rate turbulence parameters in patients after acute myocardial infarction treated invasively. Kardiol Pol. 2016;74(3):274–9.PubMedCrossRefPubMedCentralGoogle Scholar
  130. 130.
    Staessen JA, Ginnochio G, Thijs L, Fagard R. Conventional and ambulatory blood pressure and menopause in a prospective population study. J Hum Hypertens. 1997;11:507–14.PubMedCrossRefPubMedCentralGoogle Scholar
  131. 131.
    Staessen JA, Wang J, Bianchi G, Birkenhäger WH. Essential hypertension. Lancet. 2003;361:1629–38.PubMedCrossRefPubMedCentralGoogle Scholar
  132. 132.
    Straznicky NE, Grima MT, Sari CI, et al. Neck circumference is associated with muscle sympathetic nerve activity in overweight and obese men but not women. Front Physiol. 2017;8:203. Scholar
  133. 133.
    Su H, Gorodny N, Gomez LF, et al. Atherosclerotic plaque uptake of a novel integrin tracer 18F-Flotegatide in a mouse model of atherosclerosis. J Nucl Cardiol. 2014;21:553–62.PubMedPubMedCentralCrossRefGoogle Scholar
  134. 134.
    Suto J, Satou K. Effect of the Y chromosome on plasma high-density lipoprotein-cholesterol levels in Y-chromosome-consomic mouse strains. BMC Res Note. 2014;7:393.CrossRefGoogle Scholar
  135. 135.
    Taqueti VR, Shaw LJ, Cook NR, et al. Excess cardiovascular risk in women relative to men referred for coronary angiography is associated with severely impaired coronary flow reserve, not obstructive disease. Circulation. 2017;135:566–77.CrossRefPubMedGoogle Scholar
  136. 136.
    The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2017; 24:728–53.Google Scholar
  137. 137.
    Tsioufis C, Dimitriadis K, Kordalis A. Renal denervation therapy: can it contribute to better blood pressure control in hypertension? Curr Vasc Pharmacol. 2017;16:66–9. Scholar
  138. 138.
    Urbano-Manquez A, Estruch R, Fernandez-Sola J, Nicolas JM, Pare JC, Rubin E. The greater risk of alcoholic cardiomyopathy fnd myopathy in women compared with men. JAMA. 1995;274(2):149–54.CrossRefGoogle Scholar
  139. 139.
    Vaccarino V, Abramson JL, Veledar E, Weintraub WS. Sex differences in hospital mortality after coronary artery bypass surgery: evidence for a higher mortality in younger women. Circulation. 2002;105:1176–81.PubMedCrossRefPubMedCentralGoogle Scholar
  140. 140.
    Virgen R, O’Donnell CI, Barón AE, Grunwald GK, Maddox TM, Bradley SM, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA. 2013;310:1829–36.CrossRefGoogle Scholar
  141. 141.
    Wake R, Yoshiyama M. Gender differences in ischemic heart disease. Recent Pat Cardiovasc Drug Discov. 2009;4:234–40.PubMedCrossRefPubMedCentralGoogle Scholar
  142. 142.
    Wallbach M, Lehnig LY, Schroer C, et al. Effects of baroreflex activation therapy on ambulatory blood pressure in patients with resistant hypertension. Hypertension. 2016;67:701–9.PubMedCrossRefPubMedCentralGoogle Scholar
  143. 143.
    Weinberg EO, et al. Gender differences in molecular remodeling in pressure overload hypertrophy. J Am Coll Cardiol. 1999;34:264–73.PubMedCrossRefPubMedCentralGoogle Scholar
  144. 144.
    Weyer GW, Dunlap B, Shah SD. Hypertension in women: Evaluation and management. Obstet Gynecol Clin N Am. 2016;43:287–306.CrossRefGoogle Scholar
  145. 145.
    Wilhelm-Bals A, Chehade H, Girardin E, Gonzalez E, Parvex P. [Premature kidneys and oligonephronia: long term repercussion]. [Article in French]. Rev Med Suisse. 2014;10:435-6–438-41.Google Scholar
  146. 146.
    Winkler TW, Justice AE, Graft M, et al. The influence of age and sex on genetic associations with adult body size and shape: a large-scale genome-wide interaction study. PLoS Genet. 2015;11(10):1–42.CrossRefGoogle Scholar
  147. 147.
    Woehrle H, Graml A, Weinreich G. Age- and gender-dependent adherence with continuous positive airway pressure therapy. Sleep Med. 2011;12(10):1034–6.PubMedCrossRefPubMedCentralGoogle Scholar
  148. 148.
    Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA: J Am Med Assoc. 288(3):321–33.Google Scholar
  149. 149.
    Yassin D-J, et al. Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life. J Sex Med. 2014;11:1567–76.PubMedCrossRefPubMedCentralGoogle Scholar
  150. 150.
    Yeap BB, Hyde Z, Norman PE, et al. Associations of total testosterone, sex hormone-binding globulin, calculated free testosterone, and luteinizing hormone with prevalence of abdominal aortic aneurysm in older men. J Clin Endocrinol Metab. 2010;95:1123e30.CrossRefGoogle Scholar
  151. 151.
    Young MT, Phelan MJ, Nguyen NT. A decade analysis of trends and outcomes of male vs female patients who underwent bariatric surgery. J Am Coll Surg. 2016;222(3):226–31.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Russian Society of CardiologySaint-PetersburgRussia
  2. 2.Almazov National Medical Research CentreSaint-PetersburgRussia

Personalised recommendations